↓ Skip to main content

Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

Overview of attention for article published in Trials, November 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
193 Mendeley
Title
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Published in
Trials, November 2020
DOI 10.1186/s13063-020-04839-5
Pubmed ID
Authors

Shaukat Ali, Shobha Luxmi, Fatima Anjum, Sheikh Muhammad Muhaymin, Syed Muneeb Uddin, Ayesha Ali, Mir Rashid Ali, Sohaib Tauheed, Mujtaba Khan, Mohsin Bajwa, Saif Ullah Baig, Elisha Shalim, Iqra Ahmed, Abdul Samad Khan, Saeed Quraishy

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 193 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 11%
Student > Bachelor 20 10%
Other 16 8%
Researcher 15 8%
Lecturer 11 6%
Other 45 23%
Unknown 65 34%
Readers by discipline Count As %
Medicine and Dentistry 54 28%
Nursing and Health Professions 25 13%
Social Sciences 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Unspecified 7 4%
Other 19 10%
Unknown 74 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2020.
All research outputs
#11,528,642
of 19,839,988 outputs
Outputs from Trials
#2,863
of 5,110 outputs
Outputs of similar age
#197,761
of 418,005 outputs
Outputs of similar age from Trials
#352
of 681 outputs
Altmetric has tracked 19,839,988 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,110 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,005 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 681 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.